Thermo Fisher Scientific Inc. reported consolidated earnings results for the fourth quarter and year ended December 31, 2016. For the quarter, the company reported revenues of $4,953.2 million against $4,652.5 million a year ago. Operating income was $752.6 million against $690.2 million a year ago. Income before income taxes was $651.9 million against $582.7 million a year ago. Income from continuing operations was $632.7 million against $606.3 million a year ago. Net income was $629.5 million against $602.6 million a year ago. Earnings per share diluted from continuing operations were $1.59 against $1.51 per share diluted a year ago. Adjusted operating income was $1,227.1 million against $1,081.1 million a year ago. Adjusted net income was $956.5 million against $852.9 million a year ago. Adjusted EPS were $2.41 against $2.12 per share a year ago. GAAP net cash provided by operating activities was $1,205.9 million against $1,228.1 million a year ago. Purchases of property, plant and equipment was $133.5 million against $129.4 million a year ago. For the year, the company reported revenues of $18,274.1 million against $16,965.4 million a year ago. Operating income was $2,449.2 million against $2,336.2 million a year ago. Income before income taxes was $2,023.9 million against $1,936.4 million a year ago. Income from continuing operations was $2,025.3 million against $1,980.3 million a year ago. Net income was $2,021.8 million against $1,975.4 million a year ago. Earnings per share diluted from continuing operations were $5.10 against $4.93 per share diluted a year ago. Adjusted operating income was $4,221.8 million against $3,821.7 million a year ago. Adjusted net income was $3,288.6 million against $2,971.5 million a year ago. Adjusted EPS were $8.27 against $7.39 per share a year ago. GAAP net cash provided by operating activities was $3,156.3 million against $2,816.9 million a year ago. Purchases of property, plant and equipment was $444.4 million against $422.9 million a year ago.